Trial Profile
To Evaluate the efficacy and safety of Sofosbuvir with/Without Ribavirin in patients with hepatitis C
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Jul 2017
Price :
$35
*
At a glance
- Drugs Sofosbuvir (Primary) ; Daclatasvir; Ledipasvir; Ribavirin
- Indications Hepatitis C
- Focus Expanded access; Therapeutic Use
- 17 Apr 2016 Results (n=467) accessing 6 and 12 month outcomes, presented at The International Liver Congress™ 2016
- 21 Aug 2015 New trial record